Bioquell Share Discussion Threads

[abcd1234] 22/4/2004 06:53

Also a good write-up in The Times today as well :O)



Superbug survives hospital clean-ups
The Times
Thursday 22 Apr 2004

Hospital cleaning procedures designed to wipe out the MRSA superbug reduce contamination levels by as little as 10 per cent, new research has shown.......

[shiny000] 22/4/2004 00:59

Superbug boost lifts Bioquell shares
By James Daley
Independent - 22 April 2004
Shares in Bioquell, the UK biotech firm, soared more than 19 per cent yesterday as the company announced new research demonstrating the ability of its latest product to sterilise against "superbugs" in hospitals.

Nick Adams, the chief executive, said the research was likely to open the door to a flood of new business in the UK, Europe and the US, where thousands of hospitals face the constant threat of bugs such as MRSA........


Also:
Telegraph
Research into killer 'superbug' a shot in the arm for Bioquell


Scotsmam
Conventional Cleaning has 'Little Impact on Mrsa'

[abcd1234] 21/4/2004 22:02

The story has also been picked up by the BBC News no less so watch for coverage across their media.... :O)))

Here's how they are carrying the story at the moment:


BBC NEWS
Wednesday, 21 April, 2004

Vapour could 'wipe out' superbug

Scientists have discovered a way of cleaning wards to all but ensure surfaces are free of the MRSA superbug.
But the researchers from St Thomas' Hospital, London stress they do not know if better cleaning will reduce the numbers of patients infected.

Experts agree the main way to prevent transmission is for staff to wash their hands between patients.

But it is thought staff may also pick up MRSA from surfaces such as taps and door handles and then infect patients.

Hospital-acquired infections like MRSA (methicillin resistant Staphylococcus aureus) affect around 100,000 people in England each year, costing £1 billion and causing an estimated 5,000 deaths.

'Patients infect rooms'

St Thomas' researchers looked at isolation rooms and bathrooms used by patients with MRSA and general wards and bathrooms used by patients who had not been infected.


" The next - and very important - step is to understand the impact that removing MRSA from the environment might have on patient infection rates "
Professor Gary French, St Thomas' Hospital

MRSA was found to be present in all the rooms tested.

The researchers, led by Professor Gary French, said it was not surprising that the isolation rooms were contaminated, because the patient was likely to infect the room.

But researchers also found four different types of MRSA present on beds examined in the open ward, and in a shared bathroom.

MRSA was also present on a fifth of door handles to 21 rooms used by infected patients, and 7% of door handles to 175 non-MRSA rooms.

The researchers compared traditional cleaning, using special detergents, with a hydrogen peroxide vapour - which could be used where rooms could be sealed off and treated.

The study was partly funded by Bioquel, the company which produces the vapour cleaner.

It was found only 1% of sites cleaned using the hydrogen peroxide vapour remained contaminated with MRSA, compared to 66% of those cleaned using detergents.

Potential impact

Writing in the Journal of Hospital Infection, Professor French, head of the infection department at Guy's and St Thomas' NHS Trust, said: "The distribution of the contamination and the isolation of multiple strains suggest that the environment may be an important source of hospital cross-infection."

But he stressed researchers now need to look at whether having cleaner surfaces reduces the number pf patients infected with MRSA.

"The research has demonstrated that used in certain situations, for example where we can seal off a side room which has been occupied by a patient with MRSA, this technique is extremely effective in removing MRSA from equipment and surfaces.

"The next - and very important - step is to understand the impact that removing MRSA from the environment might have on patient infection rates."

A spokeswoman for the Health Protection Agency said: "MRSA is currently thought to be primarily transmitted to patients by hands and equipment.

"The spread of MRSA and other infections on hospital wards can be limited and controlled by following good infection control procedures.

"The hospital environment such as floors and furniture and are not currently considered to be a major source of MRSA transmission.

"As the authors rightly point out further investigation of the clinical significance of hospital environmental contamination and of more effective cleaning methods are required."


BBC NEWS
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

[abcd1234] 21/4/2004 21:43

Here's the article from tonights Evening Standard....... :O)



Superbug found in half wards tested at hospital
By Isabel Oakeshott And James Rossiter,
Evening Standard
21 April 2004


Shocking new evidence of the prevalence of hospital superbugs is presented today.

Research has revealed that the killer infection MRSA was to be found in nearly half of wards and rooms tested at a London hospital.

Experts called into St Thomas' to examine new ways of wiping out the bacteria discovered it was rife on bedframes, taps, door handles and TV remote controls. The infection was widespread, even in areas where no MRSA patients had stayed.

The findings will fuel fears that superbugs are spiralling out of control in Britain's hospitals.

Critics claim hygiene standards throughout the NHS are still far too lax, putting thousands of lives at risk.

The findings come after months of research at the 1,200-bed London hospital by a team led by Professor Gary French, head of the department of infection at King's College London and Guy's and St Thomas' NHS Trust.

The report was published in this week's Journal of Hospital Medicine.

The team was called in to test a breakthrough system for eradicating the infection. During their research, they took 359 swabs, both from rooms where MRSA patients had been treated, and communal areas.

The tests were carried out on 18 ward side rooms, two four-bed ward bays, and four bathrooms recently occupied or used by patients infected with MRSA. They were also carried out on eight sites in a bathroom used by non-MRSA patients,and the frames of 23 beds on an open ward being used by non-MRSA patients.

In side-rooms, bays and bathrooms where MRSA patients had been treated, the results were positive in every case.

Half of the sites in the non-MRSA patient bathroom, and six out of nine sites in the communal bathroom area, were positive. The communal bathroom area contained two patient hoists, both of which were positive.

A total of 43 per cent of the swabs from the bedframes on open wards were positive.

Today Guys and St Thomas' tried to play down the findings. A spokeswoman said: "This research was carried out in areas where MRSA patients had been treated. That was the whole point."

However, the study makes it clear the research was not limited to isolation areas for MRSA patients. The hospital also admits that MRSA patients cannot always be cared for in isolation rooms.

However, the research showed a near eradication of superbug traces from infected rooms using blasts of a hydrogen peroxide vapour, a system used in a portable device sold by British firm BIOQUELL.

Before decontamination with the product 72per cent of swabs tested positive. After decontamination only one swab - 1.2 per cent - was positive.


Daily Mail Group/London Evening Standard
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

[onehanded] 21/4/2004 21:40

Hey still got 25% of my original stock I never sold. Looking to sell tomorrow, on another day of gains. Going to get into another small company about to go up big time. USA company called Material Techo MTNA. Worth a look at. Told you this was a buy and now switching into another gem. Again will need to sit tight for up to a year to collect the real gains.

[abcd1234] 21/4/2004 21:33

From tonight's Evening Standard / Daily Mail Group:




Beyond the Footsie: Wednesday close
21 April 2004



Bioquell gained 31p to 191p, lifted by a positive research paper published today by the Journal of Hospital Infection.

The report stated that while conventional cleaning is not effective against the MRSA 'superbug', Bioquell's technology is dramatically effective.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

[peedlep] 21/4/2004 17:08

A good piece of coverage on page 2 in tonights London Evening Standard. Under the headline 'Superbug Found in Half Wards Tested at Hospital' there is reference to Bioquell and the success of their decontamination product.

[abcd1234] 21/4/2004 16:18

Should see some nice press coverage of BQE :O)

[alig14] 21/4/2004 15:46

What a rise so far. I would have liked it to rise constantly like it has for the past week. This sort of rise is always dangerous. But you never know BQE could explode.

[mclellan] 21/4/2004 15:40

This BB is always very quiet, given that this share has done very well recently.

[gdale1] 21/4/2004 15:21

At this rate £2.00 will be here quicker than you thought

[alig14] 21/4/2004 14:35

IMHO i think £2 is not far away. Price rising steadily with little volume and now that the research note is out people will seriously start looking at this co.

[gdale1] 19/4/2004 08:17

Any idea where this is going to?

[puregenius] 16/4/2004 16:01

They were out on 6 Apr

[mykai] 13/4/2004 19:56

Does anyone know exactly when the acc ounts are due

[peedlep] 05/4/2004 16:18

I think their results are out very soon (ie within the week) and I am guessing this is a good sign of what's to come.

[abcd1234] 05/4/2004 15:59

any ideas as to what is moving this up, this afternoon??
ta

[peedlep] 05/3/2004 10:08

Does anyone know what date their results are due? TIA

[square1] 20/2/2004 15:01

Starting to look interesting again IMHO. Have been adding last 2 days.

[jeffsharpe] 16/12/2003 12:39

How about them now they're £1.08?

[jeffsharpe] 11/12/2003 00:51

Now 95p - r they still worth a punt?

[jeffsharpe] 11/12/2003 00:51

Now 95p - r they still worth a punt?

[willo] 08/12/2003 16:43

Who knows - the market is certainly strong today with volume that we haven't seen for a while. Perhaps a delayed response to last week's director's share purchase.